title: Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.
abstract: Hydroxypropyl methylcellulose (HPMC) tablets containing nicotine-magnesium aluminum silicate (NCT-MAS) complex particles and pH modifiers, namely, sodium chloride, citric acid, and magnesium hydroxide, were prepared using the direct compression method. The effects of HPMC viscosity grades and pH modifiers on NCT release and permeation of the matrix tablets were examined. The results showed that the higher the viscosity grade of HPMC that was used in the tablets, the lower was the unidirectional NCT release rate found. The unidirectional NCT permeation was not affected by the viscosity grade of HPMC because the NCT diffusion through the mucosal membrane was the rate-limiting step of the permeation. Incorporation of magnesium hydroxide could retard NCT release, whereas the enhancement of unidirectional NCT release was found in the tablets containing citric acid. Citric acid could inhibit NCT permeation due to the formation of protonated NCT in the swollen tablets at an acidic pH. Conversely, the NCT permeation rate increased with the use of magnesium hydroxide as a result of the neutral NCT that formed at a basic microenvironmental pH. The swollen HPMC tablets, with or without pH modifiers, gave sufficient adhesion to the mucosal membrane. Furthermore, the addition of magnesium hydroxide to the matrix tablets was the major factor in controlling buccal delivery of NCT. This study suggests that the NCT-MAS complex-loaded HPMC tablets, which contained magnesium hydroxide, are potential buccal delivery systems of NCT.
authors.affiliation: Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand. thaned@kku.ac.th
authors.forename: Thaned
authors.initials: T
authors.lastname: Pongjanyakul
authors.forename: Sopaphan
authors.initials: S
authors.lastname: Kanjanabat
mesh_terms: D000268:Adhesiveness; D000278:Administration, Buccal; D017607:Aluminum Compounds; D000538:Aluminum Silicates / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D002626:Chemistry, Pharmaceutical; D019343:Citric Acid / Q000737:chemistry; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004947:Esophagus / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D065347:Hypromellose Derivatives; D007700:Kinetics; D008274:Magnesium / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D017616:Magnesium Compounds; D008276:Magnesium Hydroxide / Q000737:chemistry; D008567:Membranes, Artificial; D008747:Methylcellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D009092:Mucous Membrane / Q000378:metabolism; D009538:Nicotine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000737:chemistry* / Q000378:metabolism; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D010539:Permeability; D017640:Silicates; D012965:Sodium Chloride / Q000737:chemistry; D012995:Solubility; D013552:Swine; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000379:methods; D014783:Viscosity
chemical_list: D017607:Aluminum Compounds; D000538:Aluminum Silicates; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D017616:Magnesium Compounds; D008567:Membranes, Artificial; D018722:Nicotinic Agonists; D017640:Silicates; D013607:Tablets; D019343:Citric Acid; D065347:Hypromellose Derivatives; D012965:Sodium Chloride; D009538:Nicotine; C033065:aluminum magnesium silicate; D008747:Methylcellulose; D008274:Magnesium; D008276:Magnesium Hydroxide